Mary Kemp
Physician Assistant · Richmond, VANPI 1356567689
Payments from drug & device makers
Across 418 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$1K
- Insulet Corporation$594
- Abbott$531
- Amgen$450
- Boehringer Ingelheim$350
- plus $4K from 40 others
What the payments were for
- Food & beverage$8,032100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$247
- CeQur Simplicity$122
How this compares
$8,032 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $20,501 |
| MounjaroTirzepatide | 14 | $16,209 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $3,756 |
| Valsartan | 50 | $928 |
| Duloxetine Hcl | 24 | $512 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $492 |
| Escitalopram Oxalate | 48 | $464 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 38 | $261 |
| Levothyroxine Sodium | 20 | $212 |
| Cefdinir | 13 | $203 |
| Bupropion XlBupropion Hcl | 19 | $185 |
| Metformin Hcl ErMetformin Hcl | 24 | $174 |
| Amlodipine Besylate | 61 | $161 |
| Methylprednisolone | 22 | $139 |
| Cephalexin | 23 | $117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,115 | $20,50118 claims |
| Lilly USA, LLCMounjaro | $1,038 | $16,20914 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $140 | $21220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Richmond
- Robert HigginsonRichmond$66K
- Sarah HubbardRichmond$35K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Jameka McElroy-BrooklynArlington$65K
- Hillary HartungNorfolk$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.